Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer

c-Abl regulates estrogen receptor α transcription activity through its stabilization by phosphorylation

(2010) X He et al.   ONCOGENE

Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer

(2009) Janna Paulsson et al.   AMERICAN JOURNAL OF PATHOLOGY

Extended kinase profile and properties of the protein kinase inhibitor nilotinib

(2009) Paul W. Manley et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Reciprocal regulation of Abl and receptor tyrosine kinases

(2009) Divyamani Srinivasan et al.   CELLULAR SIGNALLING

Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response

(2009) Ton van Agthoven et al.   ENDOCRINE-RELATED CANCER

Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer

(2008) Louis Wing-Cheong Chow et al.   CANCER LETTERS

Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance

(2008) Grazia Arpino et al.   ENDOCRINE REVIEWS

Tyrosine Phosphorylation of the Nuclear Receptor Coactivator AIB1/SRC-3 Is Enhanced by Abl Kinase and Is Required for Its Activity in Cancer Cells

(2008) A. S. Oh et al.   MOLECULAR AND CELLULAR BIOLOGY